Headquarters
Germany
Every company in the roster headquartered in Germany.
Research
Compare company financial metrics
Research adds sourced market cap, cash, runway and annualized R&D figures with metric-specific sorting.
Views
7 of 7 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Boehringer IngelheimPrivate | 39 assets: 14 approved, 10 Ph 3, 9 Ph 2, 6 Ph 1 | fenoterol/ipratropium bromidePhase 3 · AsthmaReliable signal | 6 Oct 2026BI 3000202 · Phase 1 |
 BayerBAYN · Xetra | 15 assets: 5 approved, 5 Ph 3, 3 Ph 2, 2 Ph 1 | RiociguatPhase 3 · HypertensionReliable signal | 7 Oct 2026BAY3283142 · Phase 1 |
 Exciva GmbHPrivate | 2 assets: 2 Ph 3 | DeramciclanePhase 2/3 · Alzheimer's Disease | Jan 2029Deramciclane · Phase 2/3 |
 Tubulis GmbHPrivate | 2 assets: 2 Ph 2 | TUB-040Phase 2 · Non-Small Cell Lung Cancer | Dec 2027TUB-040 · Phase 1/2 |
 CatalYm GmbHPrivate | 1 asset: 1 Ph 3 | VisugromabPhase 2/3 · Non-Small Cell Lung Cancer | 30 Apr 2028Visugromab · Phase 1/2 |
 Priavoid GmbHPrivate | 1 asset: 1 Ph 2 | PRI-002Phase 2 · Alzheimer's DiseasePartial signal | None on record |
 selectION TherapeuticsPrivate | 1 asset: 1 Ph 1 | si-544Phase 1 · PsoriasisPartial signal | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).